Crititech, Inc.
Records under this name other than the patents Crititech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,221,779 | Compositions and Methods for the Delivery of Poorly Water Soluble Drugs and Methods of Treatment Term ended Term ended Jul 2, 2024 · High confidence | Term ended | Term ended Jul 2, 2024 | High confidence |
| 10/270,854 | Compositions and methods for delivery of poorly water soluble drugs and methods of treatment Abandoned Abandoned Jun 22, 2009 | Abandoned | Abandoned Jun 22, 2009 | |
| 14/546,221 | Use of Paclitaxel Particles Abandoned Abandoned Jul 1, 2016 | Abandoned | Abandoned Jul 1, 2016 | |
| 15/261,108 | Methods for Making Compound Particles Abandoned Abandoned May 25, 2017 | Abandoned | Abandoned May 25, 2017 | |
| 15/894,513 | Equipment Assembly for and Method of Processing Particles Abandoned Abandoned Oct 5, 2020 | Abandoned | Abandoned Oct 5, 2020 | |
| 16/064,258 | System and Methods for Tissue Sterilization Abandoned Abandoned Oct 6, 2021 | Abandoned | Abandoned Oct 6, 2021 | |
| 16/239,527 | Treatment of Bladder Cancer by Local Administration of Taxane Particles Abandoned Abandoned Oct 9, 2021 | Abandoned | Abandoned Oct 9, 2021 | |
| 16/239,529 | Treatment of Bladder Cancer by Intratumoral Injection of Taxane Particles Abandoned Abandoned Jul 23, 2020 | Abandoned | Abandoned Jul 23, 2020 | |
| 16/239,530 | Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer Abandoned Abandoned Jun 17, 2020 | Abandoned | Abandoned Jun 17, 2020 | |
| 16/239,531 | Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles Abandoned Abandoned Jun 1, 2020 | Abandoned | Abandoned Jun 1, 2020 |